Sylvie Callegari, PhD profile page

Dr. Sylvie Callegari completed her PhD at the University of South Australia before moving to Göttingen, Germany for a postdoctoral position in the lab of Prof. Peter Rehling to study how proteins are imported into mitochondria. In 2019, she returned to Australia to join Prof. David Komander's lab at WEHI (the Walter and Eliza Hall Institute of Medical Research) as a senior research officer, where she has been leading the projects on mitochondrial quality control and Parkinson’s disease. She uses a range of techniques in the lab, including cutting-edge cell biology and structural biology techniques and has made key contributions to understanding what the Parkinson’s disease-linked protein PINK1 looks like and how it is activated.